We examined 2 birth cohort effects on antibiotic prescribing during the first year of life (henceforth, infancy) in Denmark: (1) the birth season effect on timing and overall occurrence of antibiotic prescribing, and (2) the birth year effect amid emerging nationwide pneumococcal vaccination programs and changing prescribing guidelines.
During early life, children are often prescribed antibiotics for bacterial infections. Approximately 20% to 50% of children's antibiotic prescriptions are used to treat nonbacterial upper respiratory tract infections, 1 -3 for which they are largely ineffective. 2, 4 -6 In Western industrialized countries in particular, increasing advocacy for rational antibiotic prescribing has been associated with decreased population-level antibiotic use. 7 -10 In addition, pneumococcal conjugate vaccination (PCV) programs have been associated with decreased risk of acute otitis media and lower respiratory tract infections, 11 2 of the most common indications for antibiotics in children. 4, 12 -16 Taken together, there is a need to better characterize the changing patterns of antibiotic prescribing in children.
Previous studies of trends in early life antibiotic prescribing have focused on rates in cross-sectional population samples, 3, 8, 9 , 17 -23 counting multiple prescriptions per child and tending to present results for coarse age groups (eg, 0-4 years) or groups defined by the year or season when they were observed (eg, during winter 2010). In addition, studies of rates implicitly estimate the frequency of providers prescribing or dispensing antibiotics to groups of children; however, studies of risk aggregate individual-level data to clarify which well-defined cohorts of children receive or redeem a given number of prescriptions over a specific follow-up interval. Currently, data are limited regarding cohort effects on the risk of overall and medicationspecific antibiotic use during early childhood.
In Denmark, recent policy and guideline changes may have induced changes in antibiotic prescribing. The Danish Health and Medicine Authority's Institute for Rational Pharmacotherapy (IRF), a government institute, issued a bulletin in 2007 with rational antibiotic prescribing guidelines. 24 In 2007, the Danish childhood vaccination program introduced the 7-valent PCV (PCV7), replacing it with the 13-valent PCV (PCV13) in 2010. 25 -27 No studies have evaluated the impact of these events on antibiotic prescribing in Denmark during the first year of life (henceforth, infancy).
Our objectives were to estimate birth season cohort effects on antibiotic prescribing during infancy in Denmark, and birth year cohort effects on antibiotic prescribing potentially brought about by the IRF bulletin and PCV programs.
MethODs
This cohort study included all live births in Denmark from 2004 to 2012, identified by using the Danish Medical Birth Registry (MBR), which has registered all live births in Denmark since 1973. 28 We used each child's unique 10-digit personal registration number to link their individual-level data across multiple registries. After excluding children with inconsistent identification information (Supplemental Information), we examined the remaining cohort from birth for 365 days or until death or emigration.
To identify birth cohorts, we grouped children by week, month, season (winter: December to February; spring: March to May; summer: June to August; autumn: September to November), and year of birth. We ascertained demographic information from the MBR and Civil Registration System 29 and used the MBR to identify clinical characteristics of the mother, pregnancy, and birth event.
Data on antibiotics
The Danish National Health Service Prescription Database contains nationwide records for all prescriptions redeemed in community pharmacies and hospitalbased outpatient pharmacies onward from 2004. 30 We used Anatomical Therapeutic Chemical (ATC) J01  codes to identify prescriptions for  systemic antibiotics redeemed from  January 1, 2004, to December 31,  2013, and classified antibiotics by  chemical substance (henceforth,  medication) .
Risk, Rate, and burden of antibiotic Prescribing
To examine differences by birth year cohort in overall and medicationspecific prescribing, we estimated 3 measures of antibiotic prescribing: (1) 1-year risk of at least 1 redeemed antibiotic prescription during infancy by using Kaplan-Meier methods to account for censoring at death or emigration; (2) incidence rate of redeemed antibiotic prescriptions, allowing for multiple redeemed prescriptions per infant (henceforth, rate); and (3) 1-year burden of antibiotic prescriptions, on the basis of the total days supplied for redeemed antibiotic prescriptions throughout infancy. For rate and burden, we also computed each medication's share of overall prescribing, ie, the proportion of all antibiotic prescriptions (for the rate) or all days supplied (for the burden).
birth season cohort effect on time to First Redeemed antibiotic Prescription
We assessed the impact of birth season on age at first redeemed antibiotic prescription during infancy by using Kaplan-Meier methods to account for censoring at death or emigration. Infants were stratified by birth season cohort and assessed using age as the time scale. We estimated the hazard (ie, instantaneous risk) function for first redeemed antibiotic prescription and the Kaplan-Meier-derived risk function over 1 year for having at least 1 redeemed antibiotic prescription during infancy.
Interrupted time series analysis
To estimate trend changes in antibiotic prescribing over time, we used segmented linear regression analysis of interrupted time series data, 31 -34 a common quasiexperimental method to assess trend changes after clearly defined events. Separately for each birth week cohort, we estimated the 1-year risk of redeeming at least 1 prescription for any antibiotic, with subanalyses for amoxicillin and penicillin V.
We identified 5 time-based interruptions when a populationlevel change in Denmark could have altered antibiotic prescribing in infants born before versus after the interruption (Table 1) . We negatively lagged all interruptions to match each policy or guideline change with the infants subject to its potential impact. To control confounding by seasonality in our segmented linear regression model, we used a transformed cosine periodic function. 35 -37 Between any 2 interruptions, the trend estimate (ie, the change in 1-year risk during that specific time interval) resulted from the accumulation of the baseline trend and the effect of each policy or guideline change on the underlying trend. For example, for segment #3 (July 1, 2007, until January 19, 2010) the estimate was equal to the baseline trend plus the trend changes occurring at interruptions 1 and 2 (Supplemental Information).
statistical analysis
We estimated rates and burdens with corresponding 99% confidence intervals (CIs), risks with 99% pointwise CIs, and all trend estimates with 99% CIs. Hazard functions were smoothed by using a 20th-order polynomial function and plotted with 99% confidence bands. Data management and statistical analyses were conducted by using SAS version 9.4 (SAS Institute, Inc, Cary, NC), and graphics were created by using R version 3. 
Results
The final study population included 561 729 live births in Denmark occurring from 2004 to 2012. Antibiotic prescriptions accounted for 46.0% of all drug prescriptions redeemed during infancy; among 333 298 infants with a redeemed prescription for any drug, 66.2% had at least 1 antibiotic prescription.
In Table 2 , we report descriptive data for the study population along with subgroup-specific estimates of the 1-year risk for having at least DTaP/IPV/Hib, diphtheria, tetanus, acellular pertussis, polio, and Haemophilus influenzae type b.
1 redeemed antibiotic prescription during infancy. The overall 1-year risk was 39.5% (99% CI: 39.3% to 39.6%). Boys had a higher risk than girls, first-born children had a lower risk than younger siblings, and risk decreased with increasing maternal age. Maternal smoking, pregravid BMI, and prenatal clinic visit frequency were associated with higher risk. Risk increased with increasing birth weight but was not associated with gestational age. Children whose mother requested cesarean delivery had a higher risk than the general population. Geographically, risk was highest in Zealand and Southern Denmark and lowest in Central Denmark; higher population density was associated with lower risk (Fig 1) .
The overall rate was 72 redeemed antibiotic prescriptions per 100 infant years of follow-up, and the overall burden was 67 daily doses per 10 000 infant days (Table 3) . Amoxicillin and penicillin V accounted for 89% of redeemed antibiotic prescriptions out of 22 antibiotic medications prescribed to the study population. One-year risks and rates decreased over time; however, because of increasingly concentrated prescribing to infants with at least 1 prescription, antibiotic burden among infants remained stable over time, ranging from 61 to 75 daily doses per 10 000 infant days (Supplemental Tables 4-6 ). Over time, the share of the overall antibiotic rate and burden over time increased for amoxicillin and decreased for penicillin V.
birth season cohort and time to First Redeemed antibiotic Prescription During Infancy
In Fig 2, we illustrate the joint effects of birth season cohort, seasonality of prescribing, and age on the time to first redeemed antibiotic prescription during infancy. Each birth season cohort experienced a unique order of the seasons during infancy (eg, winter-spring-summerautumn versus summer-autumnwinter-spring), inducing intractable age differences between birth season cohorts in any given season of the year (Fig 2A) . The hazard (ie, instantaneous risk) of a first redeemed antibiotic prescription varied with the seasons and peaked in February (white diamonds in Fig 2A, snowflakes in Fig 2B) . Hazard also increased with increasing age through infancy (Fig 2B, 
Interrupted time series analysis
In Fig 3, Table 7 ).
A sensitivity analysis, which added a 7-month lag to relax assumptions about the timing and duration of the effects of the bulletin and the PCV7 catch-up program, affected the trend for amoxicillin but not for penicillin V (Supplemental Information). After remaining level during the lag through January 1, 2007, the amoxicillin trend decreased precipitously through July 1, 2007, by 0.58% per month (99% CI: 0.79% to 0.37%). Trend interpretation did not change in all other sensitivity analyses (Supplemental Information).
DIscussIOn
In this nationwide cohort study of children born in Denmark, we observed decreases over time from 2004 to 2012 in the proportion of infants who received antibiotics and the overall rate of antibiotic prescriptions per infant year. For those infants who received antibiotics, there was a less pronounced decrease in the rate over time, accompanied by an increase over time in days supplied. Taken together, the increasing concentration of antibiotic prescribing in a shrinking proportion of the infant population resulted in little change over time in overall antibiotic burden. Amoxicillin, which has a more extended spectrum of antibacterial activity than penicillin V, became increasingly prominent a Column percentages for characteristics in the total study population, which sum to 100%. b Risk estimates are each subgroup's cumulative incidence for at least 1 redeemed antibiotic prescription during infancy, accounting for censoring at death or emigration; these risk estimates resemble the number of children with ≥1 prescription ÷ the number of children in the subgroup because death and emigration were rare. Risks do not sum to 100%. c Missing data occurred for parity (1.5% of children had missing values), maternal pregravid BMI (5.9%), maternal smoking during pregnancy (2.3%), gestational age at birth (0.3%), and birth weight (0.6%). 
FIGuRe 1
Geographic variation in population density and antibiotic prescribing during infancy among children born in Denmark from 2004 to 2012. A, Population density by municipality, taken from census data issued for January 1, 2012 (available from Statistics Denmark, http:// www. StatBank. dk/ bev22). B, One-year risk of redeeming at least 1 antibiotic prescription during infancy, by municipality and region. Municipalities (n = 98) and regions (n = 5) were assigned on the basis of the location of residence after birth. Artificial gaps separate the North, Central, and Southern regions; the detailed inset for the Capital region includes the island of Bornholm (to scale), located 160 km east-southeast of Copenhagen. Each region's capital city is labeled and marked by a diamond.
over time. We observed that infants' first antibiotic prescriptions occurred more frequently with increasing age and during the winter months. As a result, the association between birth season and risk of having a redeemed antibiotic prescription during infancy depended partly on age. In our interrupted time series analysis, we found that 1-year risk of at least 1 redeemed amoxicillin prescription was dynamic, decreasing after the IRF bulletin and the PCV7 catch-up program, and again after rollout of the PCV13 program.
Our risk and rate estimates corroborate previous findings from substantially smaller studies on antibiotic prescribing among infants in Europe. 20, 39 Previous studies 8, 9, 17 -21 of antibiotic prescribing have focused on estimating rates. We used granularly defined time scales to provide new information on overall and medication-specific antibiotic prescribing patterns, seasonal effects, and secular trends. We described rates (prescriptions ÷ person time) and burden (days supplied ÷ person time) but focused primarily on estimating risks. Risks provide aggregated information about individual infants with and without redeemed antibiotic prescriptions by posing the question, "in a welldefined cohort, which children had a redeemed antibiotic prescription in their first year, and when was their first prescription redeemed?" In contrast, rate and burden estimates require additional assumptions 40, 41 and tend to shift the research focus to a less strictly defined group, by asking, "how many prescriptions (or days supplied) were redeemed for children in a given subgroup, defined by calendar time or another characteristic?" We recognize that each of these questions has merit depending on the setting; however, if an investigator wishes to assess individual-level determinants of antibiotic prescribing, then the risk estimator is of primary importance.
Our results for birth season cohort effects corresponded with patterns of acute otitis media, a prominent indication for antibiotic treatment, which peaks in winter and for children >6 months old. 12 Researchers for two previous studies 18, 19 have considered seasonal differences in antibiotic prescribing in children, also showing peak prescribing in winter. However, because those studies focused on rates, interpreting seasonality was tied to time periods of peak usage rather than to intrinsically different cohorts of children (ie, birth season cohorts). Other prominent studies of antibiotic prescribing in children 1, 9, 17, 20, 39 have not included explicit assessments of seasonal differences.
These new findings on birth season cohort effects inform future researchers focused on antibiotics as the exposure in 2 ways: (1) antibiotic exposure status might differ meaningfully between children born in different seasons, and (2) birth season differences in age at first antibiotic use might modify intended or unintended effects of antibiotic treatment given some children's increased vulnerability to microbial insults in early life. 42, 43 This is the first study in which the impact of the IRF bulletin (in 2007) and PCV programs (from 2007 onward) on pediatric antibiotic prescribing patterns in Denmark is explicitly evaluated. Ecologic data on PCV receipt among children in Denmark have revealed evidence This study has limitations to consider when interpreting results. We lacked data on indication because general practitioners (GPs) (who are not mandated to record a diagnosis to issue prescriptions 48 ) administer the large majority of antibiotic prescribing for infants. This feature of the health care system limited our ability to explore infection trends coincident with antibiotic prescribing changes over time or across population subgroups. This limitation is exemplified by the differences between our observations of antibiotic dispensing trends compared with a previous description 17 of infection trends in Denmark for Mycoplasma pneumoniae and Bordetella pertussis. We also lacked individual-level data on vaccination receipt, which limited inference in the interrupted time series analysis. We note limited ability to compare results to a control population in the interrupted time series analysis 33, 49 because the IRF bulletin and PCV programs pertained to all children born in Denmark. In addition, our ability to observe stronger effects of the bulletin and PCV programs on antibiotic dispensing may have been limited by ongoing stewardship efforts and lower antibiotic utilization in Denmark compared with most other European countries during the study period. 8, 23 Antibiotic prescribing trends over time are driven by the prevalence and infectiousness of circulating illnesses; although we controlled for seasonality and carefully selected relevant interruptions and their onset times, our results are limited by our inability to account for underlying differences in circulating illness from year to year and other unmeasured or unknown temporal influences.
This study also has several strengths. The registry databases facilitated our implementation of a large, welldefined, nationwide, populationbased cohort study of all children born in Denmark during this 9-year period when antibiotic prescribing practices were in transition. The tax-supported health care system for the entire Danish population includes free access to medical care and partial reimbursement of prescribed medications, 29 leading to minimal disparity in access to health care services in this study. In our study, we linked individual-level data across multiple registries to compare infants' redeemed antibiotic prescriptions with demographic and health-related characteristics. Furthermore, the registries that we PEDIATRICS Volume 140, number 3, September 2017 9 diamonds show the average hazard, for all infants combined, during each month on the calendar time scale; to avoid redundancy, average monthly hazards are plotted once. B, Hazard functions for a first redeemed antibiotic prescription by age, in months, among infants grouped by birth season cohort. Black diamonds show the average hazard for all infants combined at each month of age. Snowflake colors indicate the birth season cohort experiencing February (ie, peak hazard), which occurs at different ages for different birth season cohorts. C, Risk functions for at least 1 redeemed antibiotic prescription by age, in months, among infants grouped by birth season cohort. Black squares show the average risk of at least 1 redeemed antibiotic prescription for all infants combined at each month of age. Snowflakes same as in panel B.
FIGuRe 3
Segmented trend estimates across calendar time birth cohorts for the 1-year risk (%) of having at least 1 redeemed antibiotic prescription during infancy in Denmark from 2004 to 2012. Trends across birth cohorts (bold lines) and pointwise birth week-specific risks (faded) are shown for any antibiotic (black), amoxicillin (red), and penicillin V (blue). Interruptions are denoted by downward arrows. Trend estimates are listed for each segment as the change in 1-year risk (%) per month of birth, and are adjusted for seasonality by using a transformed cosine periodic function.
used for this study contain accurate data on the date and medication type of redeemed antibiotic prescriptions, date of birth, residence, and other variables we assessed. 28 -30 Our estimates for the total birth season cohort effect on antibiotic prescribing are unlikely to be confounded because season of birth is not affected by other risk factors for antibiotic use during infancy (eg, birth order, sex, gestational age at birth). 50 Throughout the study period, population-level characteristics of children born in Denmark did not change, no new antibiotic formulations were introduced, and the government's administrative system for prescribing and dispensing antibiotics to infants did not change. Stability of the study population and data systems during the study period limits potential for the interrupted time series study to be biased by confounding, measurement error, or cointervention effects. 32, 49 cOnclusIOns Children's season of birth impacted both their overall risk of having a redeemed antibiotic prescription during infancy and their age at first redeemed antibiotic prescription. Antibiotic prescribing was dynamic over the study period but decreased after a bulletin with guidelines on rational antibiotic use in general practice and rollout of 2 nationwide PCV programs. The approaches used in this study provide a working example of how "big data" can enable researchers to extract new information on risk, rate, and burden measures of antibiotic prescribing in infants, including the correlation between these measures. Finally, these birth cohort effects have implications for future studies of antibiotic stewardship, effectiveness, and safety in children, because some children may be inherently more susceptible than others to downstream effects of antibiotics.
